Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-Month Safety Follow-up Trial of Subjects From MannKind Protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030

NCT00741429 is registered in ClinicalTrials.gov with Mannkind Corporation as lead sponsor.

NCT NCT00741429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00741429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-Month Safety Follow-up Trial of Subjects From MannKind Protocols MKC-TI-009, MKC-TI-102, MKC-TI-103 and MKC-TI-030
Lead sponsor
Mannkind Corporation
Phase
Observational
Overall status
Completed
Start date
May 31, 2007
Completion date
September 30, 2008
Enrollment
649 (actual)
Sites
150

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes, type 2 diabetes